{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T15:22:24Z","timestamp":1780672944146,"version":"3.54.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:00:00Z","timestamp":1605657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:00:00Z","timestamp":1605657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"AMO Japan"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To investigate the effects of cataract surgery in Japanese patients with neovascular age-related macular degeneration (nAMD).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The primary endpoint in this prospective, observational study was patient satisfaction at 6 months after cataract surgery in patients with nAMD. Secondary endpoints comprised changes in best-corrected visual acuity (BCVA), M-chart score, central retinal thickness (CRT), AMD status, and number of AMD treatments. All examinations were performed before surgery, and at 1, 3, and 6 months postoperatively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Fifty patients (52 eyes) were included in this study (32 men; mean age, 76.1 \u00b1 7.1 years). Thirty-nine patients (75.0%) reported satisfaction with cataract surgery. BCVA significantly improved at all postoperative timepoints (all <jats:italic>p<\/jats:italic> &lt; 0.0001), whereas differences in M-chart scores were not statistically significant. The number of eyes with BCVA \u2264 0.3 logarithm of the minimum angle of resolution (logMAR) increased from 21 to 38; however, CRT did not change. The number of AMD treatments did not change during follow-up. All questionnaire scores showed postoperative improvement. Univariate and multivariate analyses revealed that final BCVA \u2264 0.3 logMAR was significantly associated with patient satisfaction.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Cataract surgery significantly improved vision in Japanese patients with nAMD, without affecting AMD status. Patients were satisfied with cataract surgery, especially with respect to improvement of distance vision.<\/jats:p>\n                \n              <\/jats:sec>","DOI":"10.1007\/s00417-020-05015-w","type":"journal-article","created":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T04:43:18Z","timestamp":1605674598000},"page":"1145-1151","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Effects of cataract surgery in Japanese patients with neovascular age-related macular degeneration"],"prefix":"10.1007","volume":"259","author":[{"given":"Fumi","family":"Nishiguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Amaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Komuku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0807-8817","authenticated-orcid":false,"given":"Fumi","family":"Gomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,18]]},"reference":[{"key":"5015_CR1","unstructured":"United Nations (2019) World population ageing 2019: highlights (ST\/ESA\/SER.A\/430). Population Division (2019), New York. https:\/\/www.un.org\/en\/development\/desa\/population\/publications\/pdf\/ageing\/WorldPopulationAgeing2019-Highlights.pdf. Accessed On 19 Sep 2020"},{"key":"5015_CR2","doi-asserted-by":"publisher","first-page":"e888","DOI":"10.1016\/S2214-109X(17)30293-0","volume":"5","author":"RRA Bourne","year":"2017","unstructured":"Bourne RRA, Flaxman SR, Braithwaite T et al (2017) Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis. Lancet Glob Health 5:e888\u2013e897","journal-title":"Lancet Glob Health"},{"key":"5015_CR3","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/S0140-6736(17)30544-5","volume":"390","author":"YC Liu","year":"2017","unstructured":"Liu YC, Wilkins M, Kim T et al (2017) Cataracts. Lancet 390:600\u2013612","journal-title":"Lancet"},{"key":"5015_CR4","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/S0161-6420(95)30846-9","volume":"102","author":"P Mitchell","year":"1995","unstructured":"Mitchell P, Smith W, Attebo K, Wang JJ (1995) Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 102:1450\u20131460","journal-title":"Ophthalmology"},{"key":"5015_CR5","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/S0161-6420(00)00175-5","volume":"107","author":"MR VanNewkirk","year":"2000","unstructured":"VanNewkirk MR, Nanjan MB, Wang JJ et al (2000) The prevalence of age-related maculopathy: the visual impairment project. Ophthalmology 107:1593\u20131600","journal-title":"Ophthalmology"},{"key":"5015_CR6","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0140-6736(18)31550-2","volume":"392","author":"P Mitchell","year":"2018","unstructured":"Mitchell P, Liew G, Gopinath B, Wong TY (2018) Age-related macular degeneration. Lancet 392:1147\u20131159","journal-title":"Lancet"},{"key":"5015_CR7","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ophtha.2007.03.008","volume":"115","author":"TY Wong","year":"2008","unstructured":"Wong TY, Chakravarthy U, Klein R et al (2008) The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology 115:116\u2013126","journal-title":"Ophthalmology"},{"key":"5015_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jcrs.2016.10.020","volume":"43","author":"M Lotfipour","year":"2017","unstructured":"Lotfipour M, Rolius R, Lehman EB et al (2017) Trends in cataract surgery training curricula. J Cataract Refract Surg 43:49\u201353","journal-title":"J Cataract Refract Surg"},{"key":"5015_CR9","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1167\/iovs.15-18380","volume":"57","author":"Y Tang","year":"2016","unstructured":"Tang Y, Wang X, Wang J et al (2016) Prevalence of age-related cataract and cataract surgery in a Chinese adult population: the Taizhou eye study. Invest Ophthalmol Vis Sci 57:1193\u20131200","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5015_CR10","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.oret.2019.10.019","volume":"4","author":"BJ Fenner","year":"2020","unstructured":"Fenner BJ, Ting DSW, Tan ACS et al (2020) Real-world treatment outcomes of age-related macular degeneration and polypoidal choroidal vasculopathy in Asians. Ophthalmol Retina 4:403\u2013414","journal-title":"Ophthalmol Retina"},{"key":"5015_CR11","doi-asserted-by":"publisher","first-page":"4307","DOI":"10.1167\/iovs.17-23747","volume":"59","author":"Y Gao","year":"2018","unstructured":"Gao Y, Yu T, Zhang Y, Dang G (2018) Anti-VEGF monotherapy versus photodynamic therapy and anti-VEGF combination treatment for neovascular age-related macular degeneration: a meta-analysis. Invest Ophthalmol Vis Sci 59:4307\u20134317","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5015_CR12","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10384-019-00687-2","volume":"63","author":"F Gomi","year":"2019","unstructured":"Gomi F, Migita H, Sakaguchi T et al (2019) Vision-related quality of life in Japanese patients with wet age-related macular degeneration treated with intravitreal aflibercept in a real-world setting. Jpn J Ophthalmol 63:437\u2013447","journal-title":"Jpn J Ophthalmol"},{"key":"5015_CR13","first-page":"CD006757","volume":"2","author":"H Casparis","year":"2017","unstructured":"Casparis H, Lindsley K, Kuo IC et al (2017) Surgery for cataracts in people with age-related macular degeneration. Cochrane Database Syst Rev 2:CD006757","journal-title":"Cochrane Database Syst Rev"},{"key":"5015_CR14","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1097\/OPX.0b013e31812f755f","volume":"84","author":"EL Lamoureux","year":"2007","unstructured":"Lamoureux EL, Hooper CY, Lim L et al (2007) Impact of cataract surgery on quality of life in patients with early age-related macular degeneration. Optom Vis Sci 84:683\u2013688","journal-title":"Optom Vis Sci"},{"key":"5015_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1600-0420.2004.00248.x","volume":"82","author":"SE Nilsson","year":"2004","unstructured":"Nilsson SE (2004) Are there advantages in implanting a yellow IOL to reduce the risk of AMD? Acta Ophthalmol Scand 82:123\u2013125","journal-title":"Acta Ophthalmol Scand"},{"key":"5015_CR16","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1001\/jamaophthalmol.2016.0453","volume":"134","author":"SJ Park","year":"2016","unstructured":"Park SJ, Lee JH, Ahn S, Park KH (2016) Cataract surgery and age-related macular degeneration in the 2008-2012 Korea National Health and Nutrition Examination Survey. JAMA Ophthalmol 134:621\u2013626","journal-title":"JAMA Ophthalmol"},{"key":"5015_CR17","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jcrs.2011.09.041","volume":"38","author":"E Monestam","year":"2012","unstructured":"Monestam E, Lundqvist B (2012) Long-term visual outcome after cataract surgery: comparison of healthy eyes and eyes with age-related macular degeneration. J Cataract Refract Surg 38:409\u2013414","journal-title":"J Cataract Refract Surg"},{"key":"5015_CR18","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1097\/IAE.0000000000000756","volume":"36","author":"T Schick","year":"2016","unstructured":"Schick T, Ersoy L, Lechanteur YT et al (2016) History of sunlight exposure is a risk factor for age-related macular degeneration. Retina 36:787\u2013790","journal-title":"Retina"},{"key":"5015_CR19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jcjo.2017.08.006","volume":"53","author":"K Xu","year":"2018","unstructured":"Xu K, Gupta V, Bae S, Sharma S (2018) Metamorphopsia and vision-related quality of life among patients with age-related macular degeneration. Can J Ophthalmol 53:168\u2013172","journal-title":"Can J Ophthalmol"},{"issue":"2","key":"5015_CR20","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.jcrs.2008.10.052","volume":"35","author":"M Kernt","year":"2009","unstructured":"Kernt M, Neubauer AS, Liegl R et al (2009) Cytoprotective effects of a blue light-filtering intraocular lens on human retinal pigment epithelium by reducing phototoxic effects on vascular endothelial growth factor-alpha, Bax, and Bcl-2 expression. J Cataract Refract Surg 35(2):354\u2013362","journal-title":"J Cataract Refract Surg"},{"key":"5015_CR21","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1136\/bjo.2005.086553","volume":"90","author":"MA Mainster","year":"2006","unstructured":"Mainster MA (2006) Violet and blue light blocking intraocular lenses: photoprotection versus photoreception. Br J Ophthalmol 90:784\u2013792","journal-title":"Br J Ophthalmol"},{"key":"5015_CR22","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.survophthal.2009.07.006","volume":"55","author":"MA Mainster","year":"2010","unstructured":"Mainster MA, Turner PL (2010) Blue-blocking IOLs decrease photoreception without providing significant photoprotection. Surv Ophthalmol 55:272\u2013289","journal-title":"Surv Ophthalmol"},{"key":"5015_CR23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.preteyeres.2016.04.002","volume":"53","author":"CW Wong","year":"2016","unstructured":"Wong CW, Yanagi Y, Lee WK et al (2016) Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians. Prog Retin Eye Res 53:107\u2013139","journal-title":"Prog Retin Eye Res"},{"key":"5015_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41433-018-0225-x","volume":"33","author":"Y Yanagi","year":"2019","unstructured":"Yanagi Y, Foo VHX, Yoshida A (2019) Asian age-related macular degeneration: from basic science research perspective. Eye (Lond) 33:34\u201349","journal-title":"Eye (Lond)"},{"key":"5015_CR25","doi-asserted-by":"publisher","first-page":"e0120003","DOI":"10.1371\/journal.pone.0120003","volume":"10","author":"SD Chung","year":"2015","unstructured":"Chung SD, Lee CZ, Kao LT et al (2015) Association between neovascular age-related macular degeneration and dementia: a population-based case-control study in Taiwan. PLoS One 10:e0120003","journal-title":"PLoS One"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-020-05015-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-020-05015-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-020-05015-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T04:12:54Z","timestamp":1620274374000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-020-05015-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,18]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["5015"],"URL":"https:\/\/doi.org\/10.1007\/s00417-020-05015-w","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,18]]},"assertion":[{"value":"2 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Fumi Gomi has received grants and a speaker fee from AMO Japan K. K, Bayer Yakuhin, Ltd., Novartis Pharma K.K., and Santen Pharmaceuticals Co., Ltd. Hiroto Ishikawa has received a speaker fee from AMO Japan K.K. All other authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The current study was approved by the ethics committee of Hyogo College of Medicine (approval no. 2494). The current study was performed in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The author grants the publisher the sole and exclusive license of the full copyright in the contribution, which license the publisher hereby accepts.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}